Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa05415 | Diabetic cardiomyopathy | 26/537 | 203/8135 | 0.0008179 | 0.01355 | 0.0114 | 26 | RABC4 | |
| KEGG | hsa00640 | Propanoate metabolism | 8/537 | 32/8135 | 0.0008744 | 0.01355 | 0.0114 | 8 | RABC4 | |
| KEGG | hsa04658 | Th1 and Th2 cell differentiation | 15/537 | 92/8135 | 0.0009275 | 0.01355 | 0.0114 | 15 | RABC4 | |
| KEGG | hsa05142 | Chagas disease | 16/537 | 102/8135 | 0.0009769 | 0.01355 | 0.0114 | 16 | RABC4 | |
| KEGG | hsa05146 | Amoebiasis | 16/537 | 102/8135 | 0.0009769 | 0.01355 | 0.0114 | 16 | RABC4 | |
| KEGG | hsa04510 | Focal adhesion | 36/488 | 201/8135 | 0.00000000219 | 0.000000386 | 0.000000242 | 36 | RABC5 | |
| KEGG | hsa05165 | Human papillomavirus infection | 49/488 | 331/8135 | 0.00000000241 | 0.000000386 | 0.000000242 | 49 | RABC5 | |
| KEGG | hsa04512 | ECM-receptor interaction | 20/488 | 88/8135 | 0.000000167 | 0.0000178 | 0.0000112 | 20 | RABC5 | |
| KEGG | hsa04151 | PI3K-Akt signaling pathway | 46/488 | 354/8135 | 0.000000424 | 0.000034 | 0.0000213 | 46 | RABC5 | |
| KEGG | hsa05205 | Proteoglycans in cancer | 31/488 | 205/8135 | 0.00000148 | 0.000095 | 0.0000595 | 31 | RABC5 | |
| KEGG | hsa04974 | Protein digestion and absorption | 20/488 | 103/8135 | 0.0000024 | 0.0001202 | 0.0000753 | 20 | RABC5 | |
| KEGG | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 17/488 | 79/8135 | 0.00000317 | 0.0001202 | 0.0000753 | 17 | RABC5 | |
| KEGG | hsa05022 | Pathways of neurodegeneration - multiple diseases | 54/488 | 476/8135 | 0.00000318 | 0.0001202 | 0.0000753 | 54 | RABC5 | |
| KEGG | hsa04145 | Phagosome | 25/488 | 152/8135 | 0.00000337 | 0.0001202 | 0.0000753 | 25 | RABC5 | |
| KEGG | hsa05014 | Amyotrophic lateral sclerosis | 44/488 | 364/8135 | 0.00000545 | 0.0001748 | 0.0001095 | 44 | RABC5 | |
| KEGG | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 19/488 | 100/8135 | 0.000006 | 0.000175 | 0.0001096 | 19 | RABC5 | |
| KEGG | hsa05415 | Diabetic cardiomyopathy | 29/488 | 203/8135 | 0.0000102 | 0.0002724 | 0.0001706 | 29 | RABC5 | |
| KEGG | hsa00190 | Oxidative phosphorylation | 22/488 | 134/8135 | 0.0000134 | 0.0003318 | 0.0002078 | 22 | RABC5 | |
| KEGG | hsa04926 | Relaxin signaling pathway | 21/488 | 129/8135 | 0.0000241 | 0.0005515 | 0.0003454 | 21 | RABC5 | |
| KEGG | hsa05146 | Amoebiasis | 18/488 | 102/8135 | 0.0000302 | 0.0006463 | 0.0004048 | 18 | RABC5 | |
| KEGG | hsa05020 | Prion disease | 34/488 | 273/8135 | 0.0000356 | 0.0007132 | 0.0004467 | 34 | RABC5 | |
| KEGG | hsa05017 | Spinocerebellar ataxia | 22/488 | 143/8135 | 0.0000382 | 0.0007212 | 0.0004517 | 22 | RABC5 | |
| KEGG | hsa05208 | Chemical carcinogenesis - reactive oxygen species | 29/488 | 223/8135 | 0.0000611 | 0.001089 | 0.0006824 | 29 | RABC5 | |
| KEGG | hsa03250 | Viral life cycle - HIV-1 | 13/488 | 63/8135 | 0.000073 | 0.001231 | 0.0007709 | 13 | RABC5 | |
| KEGG | hsa04935 | Growth hormone synthesis, secretion and action | 19/488 | 119/8135 | 0.0000767 | 0.001231 | 0.0007709 | 19 | RABC5 | |
| KEGG | hsa04919 | Thyroid hormone signaling pathway | 19/488 | 121/8135 | 0.0000966 | 0.001477 | 0.0009251 | 19 | RABC5 | |
| KEGG | hsa05016 | Huntington disease | 35/488 | 306/8135 | 0.0001575 | 0.002298 | 0.00144 | 35 | RABC5 | |
| KEGG | hsa05010 | Alzheimer disease | 41/488 | 384/8135 | 0.0002009 | 0.002804 | 0.001756 | 41 | RABC5 | |
| KEGG | hsa05145 | Toxoplasmosis | 17/488 | 112/8135 | 0.0003379 | 0.004519 | 0.00283 | 17 | RABC5 | |
| KEGG | hsa04929 | GnRH secretion | 12/488 | 64/8135 | 0.0003554 | 0.004563 | 0.002858 | 12 | RABC5 |